Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 684-692
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.684
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.684
Clinical management for malignant afferent loop obstruction
Arata Sakai, Hideyuki Shiomi, Atsuhiro Masuda, Takashi Kobayashi, Yasutaka Yamada, Yuzo Kodama, Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Hyogo, Japan
Author contributions: Sakai A wrote the manuscript; all authors revised the manuscript, and approved the final version.
Supported by JSPS KAKENHI , No. JP19K07938 .
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Arata Sakai, MD, PhD, Doctor, Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Hyogo, Japan. asakai@med.kobe-u.ac.jp
Received: March 4, 2021
Peer-review started: March 4, 2021
First decision: March 29, 2021
Revised: April 5, 2021
Accepted: June 18, 2021
Article in press: June 18, 2021
Published online: July 15, 2021
Processing time: 127 Days and 20.8 Hours
Peer-review started: March 4, 2021
First decision: March 29, 2021
Revised: April 5, 2021
Accepted: June 18, 2021
Article in press: June 18, 2021
Published online: July 15, 2021
Processing time: 127 Days and 20.8 Hours
Core Tip
Core Tip: Afferent loop obstruction (ALO) is defined as duodenal or jejunal mechanical obstruction at the proximal anastomosis site of a gastrojejunostomy. With advances in chemotherapy, the incidence of malignant ALO is increasing, and this condition can be complicated by ischemia, gangrenous bowel, pancreatitis, and ascending cholangitis. Moreover, the general condition of patients with recurrent cancer is often poor. Therefore, accurate and rapid diagnosis and minimally invasive treatments are required. Herein, we present recent advances in the diagnosis and treatment of malignant ALO and describe future perspectives.